The medication for the treatment of intestinal infections :: The total survey results of 2013 by the integrated assestment

The total survey results of 2013 by the integrated assestment in category

Digestive system and hepatology / The medication for the treatment of intestinal infections

Integrated, “absolute” ratings is calculated by survey results of 3 respondent groups.

	Consumers (40%)
	Experts (40%)
	Celebrities (20%)

The Favorites of the Year is determined by the Consumers (non-indifferent public), Experts (authoritative specialists of this market industry) and Celebrities Jury (known public figures and celebrities).

In forming of the integrated ratings, the following weight is assumed:

Absolute rank = (average yearly rank of Consumers × 0.4) + (rank of Experts × 0.4) + (rank of Celebrities × 0.2).

1.	2	Atoxil (Orisil-Pharm)	5

2.	1	Нифуроксазид (Gedeon Richter)	4.50

3.		Нифуроксазид (Ternopharm)	2.91

4.		Ентерол (Біокодекс Україна)	2.38

5.	4	Фталазол (Darnitsa)	2.25

6.	7	Ентобан (Herbion)	0.56

7.	6	Фталазол-Здоров’я (Pharmaceutical company “Zdorovya”)	0.25

8.	5	Фталазол (Lab. Ofichem)	0.16

9.	8	Фталазол-КМП (Arterium Corporation)	0.13

The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2013 in the “The drug for the treatment of intestinal infections” category!

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.